Vaccine-resistant pneumonia has increased since a vaccine targeting 13 serotypes of the Streptococcus pneumoniae bacteria was introduced into the Australian routine childhood immunisation program.
Projects that will address institutional racism in Australia’s healthcare system, develop new treatments for children with brain cancer, and improve personalised treatments for high-risk children’s cancer have received NHMRC funding.
The two projects aim to produce materials used in electronic, magnetic, and optical devices and infrastructure for the bioprinting of 3D models of organs and tissues.
